Yes, there is a vaccine for the flu, and it has been available for decades. Unlike a one-time vaccination, though, the flu shot is updated and administered every year because influenza viruses mutate constantly. For the 2025-2026 season, all flu vaccines in the United States are trivalent, meaning they protect against three circulating strains: two influenza A viruses (H1N1 and H3N2) and one influenza B virus.
How the Flu Vaccine Works
Flu vaccines introduce harmless pieces of influenza virus proteins into your body. Your immune system recognizes these fragments as foreign and builds antibodies specifically designed to neutralize the real virus if you encounter it later. These antibodies target a protein on the surface of the influenza virus, blocking it from infecting your cells.
It takes about two weeks after vaccination for your body to build up enough antibodies to be fully protected. That protection then gradually weakens over the following months, which is one reason you need a new shot each year. The other reason is that the virus itself changes, so the vaccine formula has to be updated to match whichever strains scientists expect to circulate that season.
Types of Flu Vaccines Available
You have several options depending on your age, health status, and preferences.
Standard inactivated shots are the most common. These use killed virus grown in eggs or cell cultures and are given as an injection, typically in the upper arm. They’re approved for nearly everyone six months and older.
Recombinant vaccines (sold as Flublok) are made synthetically in a lab without using eggs or any live virus at all. The FDA approved an updated version in March 2025 for people ages 9 and older. This is one of two completely egg-free options on the market.
Nasal spray vaccines (FluMist) use weakened live viruses and are sprayed into the nose rather than injected. In September 2024, the FDA approved FluMist for self-administration or caregiver administration at home, making it the first flu vaccine you can give yourself outside a clinic. It’s approved for people ages 2 through 49 who aren’t pregnant or immunocompromised.
High-dose and adjuvanted vaccines are designed specifically for adults 65 and older, whose immune systems typically produce a weaker response to standard shots. The CDC preferentially recommends these enhanced versions for that age group, though a standard-dose vaccine is still better than skipping vaccination entirely if the higher-dose options aren’t available.
How Effective Is It?
Flu vaccine effectiveness varies significantly from year to year. CDC data going back to 2004 shows effectiveness ranging from as low as 10% in the 2004-2005 season to as high as 60% in 2010-2011. The most recent seasons have landed in the middle: 44% in 2023-2024, 56% in 2024-2025, and 36% in 2025-2026.
Those numbers might sound underwhelming compared to vaccines for measles or polio, but they reflect a unique challenge. Influenza mutates rapidly, and scientists must choose the vaccine strains months before flu season begins. When their predictions closely match what actually circulates, effectiveness climbs. When there’s a mismatch, it drops. Even in lower-effectiveness years, vaccinated people who do get the flu tend to have milder illness, fewer complications, and shorter recovery times.
When to Get Vaccinated
September and October are the ideal months for most people. The goal is to be fully protected by the time flu activity picks up, which typically happens between October and February in the Northern Hemisphere. Getting vaccinated too early, in July or August, can be a problem because your antibody levels may decline before the season ends. This is especially relevant for adults 65 and older and people who are pregnant in the first or second trimester.
That said, getting vaccinated later in the season still offers protection. Flu activity can persist into March or April, so a January shot is better than no shot at all.
Side Effects
Many people experience no side effects. When they do occur, they’re mild and resolve on their own within a few days. For injectable vaccines, the most common reactions are soreness, redness, or swelling at the injection site, along with muscle aches, headache, fatigue, or a low-grade fever.
The nasal spray version has a slightly different side effect profile. Adults may notice a runny nose, sore throat, headache, or cough. Children can experience similar symptoms plus occasional vomiting or wheezing. Serious allergic reactions are rare with any type of flu vaccine.
Options for Egg Allergies
If you have an egg allergy, you still have options. Two egg-free flu vaccines are licensed in the United States: the recombinant vaccine (Flublok) and the cell culture-based vaccine. Neither uses eggs at any stage of production. Current CDC guidance states that people with egg allergies can receive any flu vaccine appropriate for their age and health status, including egg-based versions, but the egg-free options eliminate the concern entirely.
What’s on the Horizon
Several companies are developing mRNA-based flu vaccines using the same technology behind COVID-19 vaccines. Moderna filed for marketing authorization of its mRNA flu vaccine candidate with regulators in the U.S., Europe, Canada, and Australia in early 2026 after reporting preliminary results from a large phase 3 trial. Pfizer is also running clinical trials on its own mRNA flu vaccine. If approved, these could eventually allow faster production and potentially better strain matching, since mRNA vaccines can be manufactured more quickly than traditional egg-based versions.